Adenosine instead of supranormal potassium in cardioplegic solution improves cardioprotection

European Journal of Cardio-thoracic Surgery

Volumn 32, Issue 3, 2007, Pages 493-500

  Jakobsen, Øyvind ^a   Muller, Stig ^a   Aarsæther, Erling ^a   Steensrud, Tor ^a   Sørlie, Dag G ^a  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Adenosine; Cardioplegia; Energetics; Myocardial protection

Indexed keywords

ADENOSINE; CARDIOPLEGIC AGENT; MAGNESIUM; POTASSIUM; PROCAINE; TROPONIN T;

ANIMAL EXPERIMENT; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; DRUG MECHANISM; ENERGY TRANSFER; HEART ARREST; HEART FUNCTION TEST; HEART PROTECTION; HEMODYNAMICS; NONHUMAN; PRIORITY JOURNAL;

ADENOSINE; ANIMALS; CARDIOPLEGIC SOLUTIONS; HEART ARREST, INDUCED; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; POTASSIUM; RANDOM ALLOCATION; SWINE;

EID: 34547650601     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2007.05.020     Document Type: Article

References (24)

1. Chambers D.J. Mechanisms and alternative methods of achieving cardiac arrest. Ann Thorac Surg 75 (2003) S661-S666
2. Chambers D.J., and Hearse D.J. Developments in cardioprotection: 'polarized' arrest as an alternative to 'depolarized' arrest. Ann Thorac Surg 68 (1999) 1960-1966
3. Mankad P.S., Chester A.H., and Yacoub M.H. Role of potassium concentration in cardioplegic solutions in mediating endothelial damage. Ann Thorac Surg 51 (1991) 89-93
4. Vinten-Johansen J., Thourani V.H., Ronson R.S., Jordan J.E., Zhao Z.Q., Nakamura M., Velez D., and Guyton R.A. Broad-spectrum cardioprotection with adenosine. Ann Thorac Surg 68 (1999) 1942-1948
5. Thourani V.H., Ronson R.S., Van Wylen D.G., Shearer S.T., Katzmark S.L., Zhao Z.Q., Han D.C., Guyton R.A., and Vinten-Johansen J. Adenosine-supplemented blood cardioplegia attenuates postischemic dysfunction after severe regional ischemia. Circulation 100 (1999) II376-II383
6. Mentzer Jr. R.M., Birjiniuk V., Khuri S., Lowe J.E., Rahko P.S., Weisel R.D., Wellons H.A., Barker M.L., and Lasley R.D. Adenosine myocardial protection: preliminary results of a phase II clinical trial. Ann Surg 229 (1999) 643-649
7. Dobson G.P., and Jones M.W. Adenosine and lidocaine: a new concept in nondepolarizing surgical myocardial arrest, protection, and preservation. J Thorac Cardiovasc Surg 127 (2004) 794-805
8. Schubert T., Vetter H., Owen P., Reichart B., and Opie L.H. Adenosine cardioplegia. Adenosine versus potassium cardioplegia: effects on cardiac arrest and postischemic recovery in the isolated rat heart. J Thorac Cardiovasc Surg 98 (1989) 1057-1065
9. Corvera J.S., Kin H., Dobson G.P., Kerendi F., Halkos M.E., Katzmark S., Payne C.S., Zhao Z.Q., Guyton R.A., and Vinten-Johansen J. Polarized arrest with warm or cold adenosine/lidocaine blood cardioplegia is equivalent to hypothermic potassium blood cardioplegia. J Thorac Cardiovasc Surg 129 (2005) 599-606
10. Moser G.H., Schrader J., and Deussen A. Turnover of adenosine in plasma of human and dog blood. Am J Physiol 256 (1989) C799-C806
11. Obata T., Hosokawa H., Soeda T., Karashima K., Uchida Y., and Yamanaka Y. Myocardial microdialysis of salicylic acid to detect hydroxyl radical generation during ischemia. Comp Biochem Physiol B Biochem Mol Biol 110 (1995) 277-283
12. Baan J., van der Velde E.T., de Bruin H.G., Smeenk G.J., Koops J., van Dijk A.D., Temmerman D., Senden J., and Buis B. Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation 70 (1984) 812-823
13. Suga H. Ventricular energetics. Physiol Rev 70 (1990) 247-277
14. Ralevic V., and Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 50 (1998) 413-492
15. Szentmiklosi A.J., Nemeth M., Szegi J., Papp J.G., and Szekeres L. Effect of adenosine on sinoatrial and ventricular automaticity of the guinea pig. Naunyn Schmiedebergs Arch Pharmacol 311 (1980) 147-149
16. Louttit J.B., Hunt A.A., Maxwell M.P., and Drew G.M. The time course of cardioprotection induced by GR79236, a selective adenosine A1-receptor agonist, in myocardial ischaemia-reperfusion injury in the pig. J Cardiovasc Pharmacol 33 (1999) 285-291
17. Auchampach J.A., Rizvi A., Qiu Y., Tang X.L., Maldonado C., Teschner S., and Bolli R. Selective activation of A3 adenosine receptors with N6-(3-iodobenzyl)adenosine-5′-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits. Circ Res 80 (1997) 800-809
18. Miura T., Liu Y., Kita H., Ogawa T., and Shimamoto K. Roles of mitochondrial ATP-sensitive K channels and PKC in anti-infarct tolerance afforded by adenosine A1 receptor activation. J Am Coll Cardiol 35 (2000) 238-245
19. Bolling S.F., Childs K.F., and Ning X.H. Adenosine's effect on myocardial functional recovery: substrate or signal?. J Surg Res 57 (1994) 591-595
20. Foker J.E., Einzig S., and Wang T. Adenosine metabolism and myocardial preservation. Consequences of adenosine catabolism on myocardial high-energy compounds and tissue blood flow. J Thorac Cardiovasc Surg 80 (1980) 506-516
21. Jovanovic A., Alekseev A.E., Lopez J.R., Shen W.K., and Terzic A. Adenosine prevents hyperkalemia-induced calcium loading in cardiac cells: relevance for cardioplegia. Ann Thorac Surg 63 (1997) 153-161
22. Fishbein M.C., Wang T., Matijasevic M., Hong L., and Apple F.S. Myocardial tissue troponins T and I. An immunohistochemical study in experimental models of myocardial ischemia. Cardiovasc Pathol 12 (2003) 65-71
23. Halestrap A.P., Clarke S.J., and Javadov S.A. Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection. Cardiovasc Res 61 (2004) 372-385
24. Caputo M., Bryan A.J., Calafiore A.M., Suleiman M.S., and Angelini G.D. Intermittent antegrade hyperkalaemic warm blood cardioplegia supplemented with magnesium prevents myocardial substrate derangement in patients undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg 14 (1998) 596-601